(1) Background: Hormone receptor positive breast cancer is a subtype of breast cancer with relatively good prognosis, but luminal B (HER–2 negative) breast cancer has a higher risk of recurrence and metastasis. This evidence concerns the gene ERBB2 and breast cancer.